Abstract

Objective Combining information derived from cellular biomarkers as telomerase and genes encoding cyclin dependent kinase inhibitors (p16 INK4a and p15 INK4b) is needed to facilitate the stratification of individual patients within the conventional clinicopathologic parameters. Design and methods One hundred forty laryngeal squamous cell carcinoma (LSCC) tissue specimens were investigated for telomerase activity and the deletions of p16 INK4a and p15 INK4b genes. Results Of the 140 tissues assayed, 71% demonstrated high telomerase activity, 68.6% and 80% showed deletions in p16 INK4a and p15 INK4b genes, respectively. Significant difference was observed between telomerase activity, p16 INK4a and p15 INK4b deletions among each other and with advanced stage, poorly differentiated grades, high proliferation and DNA aneuploidy. The markers and the aforementioned clinicopathological factors were correlated with progression in univariate analysis; and associated with survival in multivariate analysis. Conclusion Progression of LSCC is accompanied by a parallel increase in telomerase activity and deletions in cell-cycle regulators (p16 INK4a, p15 INK4b) which may assist in prognostication and better classification of patients for treatment.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.